Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28335433)

Published in Int J Mol Sci on March 14, 2017

Authors

Olivier Loudig1, Tao Wang2, Kenny Ye3, Juan Lin4, Yihong Wang5, Andrew Ramnauth6, Christina Liu7, Azadeh Stark8, Dhananjay Chitale9, Robert Greenlee10, Deborah Multerer11, Stacey Honda12, Yihe Daida13, Heather Spencer Feigelson14, Andrew Glass15, Fergus J Couch16, Thomas Rohan17,18, Iddo Z Ben-Dov19

Author Affiliations

1: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Olivier.loudig@einstein.yu.edu.
2: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. tao.wang@einstein.yu.edu.
3: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. kenny.ye@einstein.yu.edu.
4: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Juan.lin@einstein.yu.edu.
5: Department of Pathology, Rhode Island Hospital, Providence, RI 02903, USA. ywang6@Lifespan.org.
6: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. andrew.ramnauth12@myhunter.cuny.edu.
7: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. christina.liu@einstein.yu.edu.
8: Department of Pathology and Breast Oncology Program, Henry Ford Health System, Detroit, MI 48202, USA. ASTARK1@hfhs.org.
9: Department of Pathology and Breast Oncology Program, Henry Ford Health System, Detroit, MI 48202, USA. dchital1@hfhs.org.
10: Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Marshfield, WI 54449, USA. greenlee.robert@mcrf.mfldclin.edu.
11: Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Marshfield, WI 54449, USA. multerer.deborah@mcrf.mfldclin.edu.
12: Department of Pathology, Center for Health Research, Kaiser Permanente, 3288 Moanalua Road, Honolulu, HI 96819, USA. Stacey.Honda@kp.org.
13: Department of Pathology, Center for Health Research, Kaiser Permanente, 3288 Moanalua Road, Honolulu, HI 96819, USA. Yihe.G.Daida@kp.org.
14: Center for Excellence in Cancer and Genomics, Kaiser Permanente Colorado, Denver, CO 80237, USA. heather.s.feigelson@kp.org.
15: Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227, USA. andy_5241@msn.com.
16: Health Sciences Research, Mayo Clinic, Rochester, NY 55902, USA. couch.fergus@mayo.edu.
17: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. thomas.rohan@einstein.yu.edu.
18: Montefiore Medical Center, Bronx, NY 10467, USA. thomas.rohan@einstein.yu.edu.
19: Laboratory of Medical Transcriptomics, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. Iddo@hadassah.org.il.

Articles cited by this

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2009) 67.17

A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09

MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 27.48

Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61

Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet (2009) 16.58

Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst (2010) 4.57

MiRNAs and cancer. Am J Pathol (2009) 3.42

A flexible R package for nonnegative matrix factorization. BMC Bioinformatics (2010) 3.28

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol (2009) 2.86

MicroRNA biogenesis pathways in cancer. Nat Rev Cancer (2015) 2.67

Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest (2009) 2.43

2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res (2009) 2.03

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol (1996) 1.88

An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J Mol Diagn (2008) 1.82

Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol Histopathol (2011) 1.68

Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res (2011) 1.49

Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol (2008) 1.44

MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int J Clin Exp Pathol (2009) 1.38

Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing. Methods (2012) 1.37

Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues. PLoS One (2013) 1.24

MicroRNA and cancer--a brief overview. Adv Biol Regul (2014) 1.22

Effective DNA/RNA co-extraction for analysis of microRNAs, mRNAs, and genomic DNA from formalin-fixed paraffin-embedded specimens. PLoS One (2012) 1.16

Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. PLoS One (2013) 1.14

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat (2000) 1.12

Robust global microRNA expression profiling using next-generation sequencing technologies. Lab Invest (2014) 1.09

Bioinformatic analysis of barcoded cDNA libraries for small RNA profiling by next-generation sequencing. Methods (2012) 1.04

Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J Pathol (2011) 0.99

High stability of microRNAs in tissue samples of compromised quality. Virchows Arch (2013) 0.98

piPipes: a set of pipelines for piRNA and transposon analysis via small RNA-seq, RNA-seq, degradome- and CAGE-seq, ChIP-seq and genomic DNA sequencing. Bioinformatics (2014) 0.95

Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes Cancer (2015) 0.92

Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: preliminary assessment of cross-platform concordance. Genomics (2013) 0.89

Accuracy of Molecular Data Generated with FFPE Biospecimens: Lessons from the Literature. Cancer Res (2015) 0.88

A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients. Sci Rep (2015) 0.88

Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT). Nucleic Acids Res (2007) 0.86

MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls. J Cell Mol Med (2012) 0.85

MicroRNA expression profiling in archival tissue specimens: methods and data processing. Mol Biotechnol (2012) 0.85